Nichols David Wayne 4
4 · Magenta Therapeutics, Inc. · Filed Apr 20, 2021
Insider Transaction Report
Form 4
Nichols David Wayne
Chief Technical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-19+175,000→ 175,000 totalExercise: $10.50Exp: 2031-04-18→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exerciseable over four years, with 25% of this option vesting on April 19, 2021, and the remainder vesting in 36 equal monthly installments thereafter.